Norway Rapid Point-of-care Testing For Sickle Cell Anemia Market Size & Outlook
Related Markets
Norway rapid point-of-care testing for sickle cell anemia market highlights
- The Norway rapid point-of-care testing for sickle cell anemia market generated a revenue of USD 2.4 million in 2025 and is expected to reach USD 4.5 million by 2033.
- The Norway market is expected to grow at a CAGR of 8.2% from 2026 to 2033.
- In terms of segment, lateral flow immunoassay was the largest revenue generating type in 2025.
- Paper-Based Rapid Diagnostics is the most lucrative type segment registering the fastest growth during the forecast period.
Rapid point-of-care testing for sickle cell anemia market data book summary
| Market revenue in 2025 | USD 2.4 million |
| Market revenue in 2033 | USD 4.5 million |
| Growth rate | 8.2% (CAGR from 2026 to 2033) |
| Largest segment | Lateral flow immunoassay |
| Fastest growing segment | Paper-Based Rapid Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Lateral Flow Immunoassay, Paper-Based Rapid Diagnostics, Others Type |
| Key market players worldwide | BioMedomics, Silver Lake Research, Bio-Rad Laboratories Inc, Trivitron Healthcare, Hemex Health, Sysmex Corporation, EKF Diagnostics Holdings PLC, Danaher Corp |
Other key industry trends
- In terms of revenue, Norway accounted for 0.7% of the global rapid point-of-care testing for sickle cell anemia market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany rapid point-of-care testing for sickle cell anemia market is projected to lead the regional market in terms of revenue in 2033.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 57.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rapid Point-of-Care Testing for Sickle Cell Anemia Market Scope
Rapid Point-of-Care Testing for Sickle Cell Anemia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Hemex Health | View profile | 1-10 | Portland, Oregon, United States, North America | http://hemexhealth.com/ |
| Silver Lake Research | View profile | 11-50 | Azusa, California, United States, North America | https://www.silverlakeresearch.com/ |
| Halcyon Biomedical | View profile | - | Friendswood, Texas, United States, North America | http://halcyonbiomedical.com |
| BioMedomics | View profile | 1-10 | Morrisville, North Carolina, United States, North America | http://biomedomics.com |
| Transasia Bio Medicals | View profile | 1001-5000 | Mumbai, Maharashtra, India, Asia | http://www.transasia.co.in |
| Trivitron Healthcare | View profile | 5001-10000 | Chennai, Tamil Nadu, India, Asia | http://www.trivitron.com |
| Mylab Discovery Solutions | View profile | 11-50 | Lonavla, Maharashtra, India, Asia | https://mylabdiscoverysolutions.com/ |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| EKF Diagnostics Holdings PLC | View profile | 356 | 19 Stanwell Road, Penarth, Avon House, Cardiff, United Kingdom, CF64 2EZ | https://www.ekfdiagnostics.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
Norway rapid point-of-care testing for sickle cell anemia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rapid point-of-care testing for sickle cell anemia market will help companies and investors design strategic landscapes.
Lateral flow immunoassay was the largest segment with a revenue share of 58.33% in 2025. Horizon Databook has segmented the Norway rapid point-of-care testing for sickle cell anemia market based on lateral flow immunoassay, paper-based rapid diagnostics, others type covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Norway rapid point-of-care testing for sickle cell anemia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway rapid point-of-care testing for sickle cell anemia market databook
-
Our clientele includes a mix of rapid point-of-care testing for sickle cell anemia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway rapid point-of-care testing for sickle cell anemia market , including forecasts for subscribers. This country databook contains high-level insights into Norway rapid point-of-care testing for sickle cell anemia market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Norway rapid point-of-care testing for sickle cell anemia market size, by type, 2021-2033 (US$M)
Norway Rapid Point-of-Care Testing for Sickle Cell Anemia Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
